No

Antifungal Agent, Topical

Topical treatment of tinea pedis (athlete's foot), tinea cruris (jock itch), tinea corporis (ringworm), tinea versicolor, and cutaneous candidiasis

C

Clinical effect on the fetus: Do not use during the 1st trimester of pregnancy, unless essential to a patient's welfare; use during the second and third trimesters only if clearly needed

Known hypersensitivity to econazole or any component

Discontinue drug if sensitivity or chemical irritation occurs; not for ophthalmic or intravaginal use

1% to 10%:

Local: Burning, stinging

No data reported

Alters fungal cell wall membrane permeability; may interfere with RNA and protein synthesis, and lipid metabolism

Absorption: Topical: <10%

Metabolism: In the liver to >20 metabolites

Elimination: <1% of applied dose recovered in urine or feces

Children and Adults: Topical:

Cutaneous candidiasis: Apply sufficient quantity twice daily (morning and evening)

Duration of treatment: Candidal infections and tinea cruris, versicolor, and corporis should be treated for 2 weeks and tinea pedis for 1 month; occasionally, longer treatment periods may be required

None reported

None reported

No information available to require special precautions

No effects or complications reported

For external use only. Apply exactly as directed and for the length of time prescribed. Report if conditions worsens or persists or if infection occurs. Pregnancy/breast-feeding precautions: Inform prescriber if you are or intend to be pregnant. Consult prescriber if breast-feeding.

Candidal infections and tinea cruris, versicolor, and corporis should be treated for 2 weeks and tinea pedis for 1 month; occasionally, longer treatment periods may be required

Cream, as nitrate: 1% (15 g, 30 g, 85 g)